Psoriasis and COVID-19: findings from PsoProtectMe.
(2023)
Conference Proceeding
McGrath, C., Yates, M., Yiu, Z., Langan, S., Tsakok, T., Dand, N., …Mahil, S. (2023). Psoriasis and COVID-19: findings from PsoProtectMe. . https://doi.org/10.55788/819f9152
All Outputs (2)
A real-world comparison of effectiveness and safety outcomes between clinical trial eligible and ineligible patients in the British Association of Dermatologists Biologic Interventions Register (BADBIR) (2018)
Conference Proceeding
Mason, K. J. (2018). A real-world comparison of effectiveness and safety outcomes between clinical trial eligible and ineligible patients in the British Association of Dermatologists Biologic Interventions Register (BADBIR).Background: There is preliminary evidence that psoriasis patients eligible for clinical trials of biologics are not representative of real-world patients. Objectives: To determine whether patients enrolled in BADBIR identified as eligible or ineli... Read More about A real-world comparison of effectiveness and safety outcomes between clinical trial eligible and ineligible patients in the British Association of Dermatologists Biologic Interventions Register (BADBIR).